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Abstract: Breast cancer is a common malignancy among women worldwide. Gelatinases such
as matrix metallopeptidase 2 (MMP2) and MMP9 play crucial roles in cancer cell migration,
invasion, and metastasis. To develop a novel platform compound, we synthesized a flavonoid
derivative, (E)-5-((4-oxo-4H-chromen-3-yl)methyleneamino)-1-phenyl-1H-pyrazole-4-carbonitrile
(named DK4023) and characterized its inhibitory effects on the motility and MMP2 and MMP9
expression of highly metastatic MDA-MB-231 breast cancer cells. We found that DK4023 inhibited
tumor necrosis factor alpha (TNFα)-induced motility and F-actin formation of MDA-MB-231 cells.
DK4023 also suppressed the TNFα-induced mRNA expression of MMP9 through the downregulation
of the TNFα-extracellular signal-regulated kinase (ERK)/early growth response 1 (EGR-1) signaling
axis. These results suggest that DK4023 could serve as a potential platform compound for the
development of novel chemopreventive/chemotherapeutic agents against invasive breast cancer.
Keywords: EGR-1; flavonoid; (E)-5-((4-oxo-4H-chromen-3-yl)methyleneamino)-1-phenyl-1H-
pyrazole-4-carbonitrile; MDA-MB-231; MMP9; TNFα
1. Introduction
Breast cancer is a common malignancy among women worldwide [1]. Metastasis, the spread of
primary tumor cells to different organs through the blood or lymphatic vessels, is a typical hallmark of
all malignant tumors and is responsible for high mortality among patients with cancer. Breast cancer
commonly spreads to the regional lymph nodes, bone, liver, lungs, and brain [2]. Thus, the control over
the process of metastasis at the early stages is imperative for the successful prevention and treatment
of cancer, including breast cancer.
Tumor cell invasion involves their migration and penetration into neighboring tissues.
Lymphovascular invasion is, in general, the first stage of carcinogenic events that initiate tumor
metastasis [3]. The initial step of invasion is characterized by the breakdown of the basement membrane,
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a sheet-like structure of the extracellular matrix secreted by the epithelium [4]. Type IV collagen is
a major component of the basement membrane, and gelatinases such as matrix metallopeptidase
9 (MMP9, also known as gelatinase B and 92 kDa type IV collagenase) and MMP2 (also known as
gelatinase A and 72 kDa type IV collagenase) are responsible for the breakdown of type IV collagen [5].
MMP2 and MMP9 expression is known to be highly upregulated in almost every metastatic cancer
cell type [5,6], and elevated MMP9 level is associated with the high potential of metastasis in several
human carcinomas, including breast cancer [6–8]. MMP9 expression has been observed in invasive
mammary carcinomas, but not in carcinomas in situ or hyperplastic mammary glands [9]. Experimental
metastasis studies have also shown that the downregulation of MMP9 expression in cancer cells by
ribozyme could reduce tumor foci in the lungs of mice [10], consistent with the results observed in
Mmp2- [10] or Mmp9-deficient mice [11]. These observations suggest that a therapeutic strategy to
manipulate MMP2 or MMP9 expression could be potentially advantageous for the development of
anti-metastatic agents.
Flavonoids have a common feature of C6-C3-C6 skeleton. One of the flavonoids, flavone is
composed of 4H-chromen-4-one for C6-C3- and benzene ring for the -C6. Compounds carrying
the 1-phenyl-1H-pyrazole moiety have been reported to exhibit antitumor activities [12] and induce
apoptosis [13]. In addition, compounds with the 4H-chromen-4-one moiety are known to demonstrate
BRAF kinase inhibitory activity [14], cytotoxicity against the breast cancer cell line MCF-7 [15], and
inhibitory effects on the p53-mouse double minute 2 (MDM2) pathway [16]. Therefore, we synthesized
a novel compound combining 1-phenyl-1H-pyrazole and 4H-chromen-4-one moieties to obtain
(E)-5-((4-oxo-4H-chromen-3-yl)methyleneamino)-1-phenyl-1H-pyrazole-4-carbonitrile (termed as
DK4023). When C2- and C3-position of flavonoids are substituted with benzene ring, they are
classified as flavone and isoflavone, respectively. Since the C3-position is substituted with
5-(methyleneamino)-1-phenyl-1H-pyrazole-4-carbonitrile, DK4023 can be classified as isoflavone
derivative. Among isoflavones, genistein and daidzein are known to inhibit TNFα-induced migration
and invasion of human breast cancer cells by preventing the inhibition of NF-κB [17]. TNFα is a
central inflammatory cytokine in the tumor microenvironment that promotes migration, invasion, and
metastasis [18–20]. In the current study, we examined the inhibitory effects of DK4023 on TNFα-induced
motility and invasive capability of the highly metastatic MDA-MB-231 breast cancer cells. In addition,
we determined the inhibitory effect of DK4023 on TNFα-induced MMP2 and MMP9 mRNA expression.
2. Results and Discussion
2.1. Chemical Synthesis and Cytotoxicity of DK4023 against MDA-MB-231 Cells
The synthesis of DK4023 was started from phenylhydrazine (I) and 2-(ethoxymethylidene)
propanedinitrile (II). The resulting 5-amino-1-phenyl-1H-pyrazole-4-carbonitrile
(III) was reacted with 4-oxo-4H-chromene-3-carbaldehyde (IV) to yield
(E)-5-((4-oxo-4H-chromen-3-yl)methyleneamino)-1-phenyl-1H-pyrazole-4-carbonitrile (V; named
DK4023) (Scheme 1).
To determine the cytotoxicity of DK4023, we treated MDA-MB-231 human breast cancer cells
with DK4023 (0, 10, 25, 50, and 100 µM) for 24 h. Cellular cytotoxicity was determined using the
water-soluble 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium,
monosodium salt (WST-8). As no significant cytotoxicity was observed at up to 50 µM DK4023
concentration (Figure 1), we used 25 and 50 µM concentrations for subsequent experiments.
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Figure 1. Cytotoxicity of DK4023 against MDA-MB-231 cells. Values are expressed as mean ± SD.
*** p < 0.001, NS not significant (p > 0.200) by Sidak’s multiple comparison test (n = 3).
2.2. Effect of DK4023 on the TNFα-Induced Migration of MDA-MB-231 Cells
The tumor mass is composed of tissue-resident fibroblasts, peripherally recruited immune cells, and
endothelial cells of surrounding blood vessels, as well as cancer cell populations. The local environment
around the tumor mass includes various growth factors and cytokines, which are collectively referred
to as a tumor microenvironment [21]. It has been well characterized that the inflammatory tumor
microenvironment is closely associated with tumor development and progression [22,23]. TNFα is a
major proinflammatory cytokine that is released from many cell types, including cancer cells, immune
cells, and fibroblasts, in the tumor microenvironment [20]. It has been demonstrated that TNFα
increases the expre ion f other cytokines and chemokines, including IL-1, IL-6, CCL2, CXCL8, and
CXCL12 [24], induces epithelial-to-mesenchymal transition (EMT), through the activation of NF-κB
a d AP1, a d facilitates the invasion and metastasis of breast cancer cell [21,25].
A crucial feature of invasive and metastatic breast cancer cells is the incre se in th ir mo ility.
To evalu te whether DK4023 could modulate the motility of metastatic MDA-MB-231 cells, we used an
in vitro cratch-wound healing assay and me sured the thickness of the scratched area. After scratching
a onfluent monolayer, cells were treated with TNFα (10 ng/ L) or TNFα (10 ng/mL) plus DK4023
(25 and 50 µM) (Figure 2a). At 12 h post-scratching, the scratched area decreased following TNFα
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treatment as compared that observed after vehicle treatment. In contrast, the TNFα-induced closure of
the scratched area was significantly suppressed in the presence of DK4023 (Figure 2b). As DK4023 did
not exhibit cytotoxicity at concentrations around 50 µM (Figure 1), its inhibitory effect on the motility
of MDA-MB-231 cells was not related to its cytotoxicity.
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Figure 2. Effect of DK4023 on the migration of MDA-MB-231 cells. (a) Scratch wound-healing assay.
DK4023 was pretreated for 30 min before addition of TNFα. Migration images were captured after 12 h
of TNFα treatment. Box areas were enlarged underneath the image. Arrow indicates the elongated
spindle shape of leader cells at the leading edge. Vehicle, phosphate-buffered saline. Scale bars, 500 µm.
(b) A plot of the scratched gap area was expressed as the number of pixels in the selected boxes. Values
were expressed as mean ± SD. * p = 0.021, *** p < 0.001 by Sidak’s multiple comparison test (n = 3).
2.3. Effect of DK4023 on the Actin Reorganization of MDA-MB-231 Cells
As shown in Figure 3, DK4023 reduced the TNFα-induced branched structures of the leader
cells at the edge (arrow). Monomeric globular actin (G-actin) is polymerized into filam ntous a tin
(F-actin), which is known t build up higher-ordered structures such as stress fibers, lamellipodia, and
filopodia during cell movement [26]. As the dynamic rearrangement of the actin cytosk leton plays a
crucial role in cell migration [27], we assessed whether DK4023 affects actin cytoskeletal rearrangement.
We used rhodamine-conjugated phalloidin to stain F-actin and found that TNFα re tment stimulated
cytoskeletal rearrangement, as evident from th formation of F-actin-rich protrusions tha appeared
like lamellipodia (arrows) at th cell periphery (Figure 3). After the treatment of cells with DK4023,
the TNFα-induced F-actin-rich protrusions were substanti lly reduced. These data sugg st that DK4023
pr vents dynamic F-ac in polymerization, resulting in the inhibition of cell m tility.
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2.4. Effect of K4023 on the Expression of P9
s gelatinases play a critical role in cell igration, invasion, and etastasis, e investigated
hether DK4023 odulates gelatinase activation. Gelatinase activity was determined using gelatin-gel
zymography. DK4023 reduced the density of TNFα-induced gelatinolytic white band at 92 k a
P9, but not that of the band at 72 kDa P2 (Figure 4a). To investigate hether DK4023-induced
suppression of P9 activity as associated ith P9 do nregulation, e deter ined the effect
of K4023 on the expression of P9 R using conventional reverse-transcription poly erase
chain reaction (RT-PCR). e found that K4023 dose-dependently inhibited T Fα-induced R
expression of P9 but not P2, hile glyceraldehyde 3-phosphate dehydrogenase ( P )
R levels re ained unchanged (Figure 4b). s T Fα induced P9 R expression and
proteolytic activity of P9 ore efficiently than P2, e focused on the inhibitory effect of
4023 on P9 expression in substantial experi ents. To further evaluate the inhibitory effect of
4023 on MMP9 expression at the transcriptional level, we measured MMP9 promoter activity using
the pMMP9(−925/+13)-Luc luciferase-based promoter-reporter plasmid [28]. TNFα stimulated MMP9
promoter activity by 3.47 ± 0.351-fold, but this effect was significantly suppressed by 2.13 ± 0.351- and
1.47 ± 0.208-fold in the presence of 25 and 50 µM DK4023, respectively (Figure 4c). Thus, DK4023
inhibits MMP9 mRNA expression.
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Figure 4. Effect of DK4023 on TNFα-induced P9 activation. Effect of DK4023 on TNFα-induced
gelatinolytic activity determined by gelatin-gel zymography (a), MMP9 and MMP2 mRNA expression
examined by RT-PCR (b), and luciferase-based MMP9 promoter-reporter activity (c). The full-length
gel images are presented in Supplementary Figure S1. Relative band intensities were measured by
ImageJ. Values are expressed as mean ± SD. * p = 0.016, ** p < 0.01, ***p < 0.001, NS, not significant
(p > 0.5) by Sidak’s multiple comparison test (n = 3).
2.5. Effect of DK4023 on the TNFα-Induced Invasion of MD-MB-231 Cells
MMP9 plays a critical role in the invasion of tumor cells through the degradation of extracellular
matrix proteins [5]. To investigate the effect of DK4023 on the invasive capability of MDA-MB-231 cells,
we used a matrigel-based three-dimensional (3-D) spheroid culture model that closely resembles the
situation inside the in vivo tumor mass. Up to 1 day, the cells within the spheroid were noninvasive
and remained as cell aggregates. (Figure 5, top panels). Following 5 days of culture, invasive
cells could be detected in vehicle-treated spheroid (Figure 5, left lane). Following treatment with
10 ng/mL TNFα, the sizes of spheroids were bigger than vehicle-treated groups, and the cells efficiently
invaded the surrounding matrix as spindle-like protrusions (Figure 5, middle lane). However, in the
presence of DK4023, TNFα-induced invasive capability was substantially attenuated (Figure 5,
right lane). These results suggest that DK4023 inhibits TNFα-induced tumor cell invasion through the
downregulation of MMP9 expression.
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Figure 5. Effect of DK4023 on the invasion of MDA-MB-231 cells. Schematic representation of
three-dimensional spheroid formation and protrusion of MDA-MB-231 cells (left). MDA-MB-231 cell
spheroids in the extracellular matrix were treated with vehicle (DMSO) or 10 ng/mL TNFα for 7 days in
the presence or absence of 25 µM DK4023. The morphology of the invasive protrusions was captured
with an EVOS FL Auto Cell Imaging System. Scale bars, 400 µm. The boxed areas are enlarged.
2.6. Effect of DK4023 on the TNFα-Induced Activation of Nuclear Factor-Kappa B (NF-κB) Pathway
NF-κB is a well-known transcription factor involved in the regulation of TNFα-induced MMP9
expression [29–32]. In unstimulated cells, RelA/p65 and p50, which are the most abu ant forms of
NF-κB heterodimers, are inhibited by IκB in the cytoplasm. Upon exposure of cells to TNFα, IκB kinase
(IKK) gets activated and phosphorylates IκB, subsequent y resulting in the degradation of IκB through
a ubiquitin-mediated proteolytic pathway [33]. We observed that TNFα enhanced th phosphorylation
of IKK and RelA/p65 in a time-dependent manner, while IκB ph sphoryla ion level increased within
10 min, then rapidly decreased, and slowly r covere there fter in MDA-MB-231 cells (Figure 6a).
To determine whether DK4023 modulates the NF-κB path a , we pr trea ed MDA-MB-231 cells with
DK4023 and measur d the TNFα-induced phosphorylation status of three key proteins, IKK, IκB,
and RelA/p65. DK4023 failed to significantly decrease the TNFα-induced phosphorylation of IKKα/β
o R lA/p65 but could significantly increase the phosph rylation of IκB (Figure 6b). These data sugg st
t at DK4023 may affect the NF-κB pathway hrough the stabilization of IκB, which could be necessary
but not sufficient to downregulate MMP9 expression.
Int. J. Mol. Sci. 2020, 21, 5080 8 of 15
Int. J. Mol. Sci. 2020, 21, x FOR PEER REVIEW 8 of 15 
 193 
Figure 6. Effect of DK4023 on the TNFα-induced activation of NF-κB pathway. (a) The TNFα-induced 194 
phosphorylation of IKKα/β on Ser-180/181, IκB on Ser-32, and RelA/p65 on Ser-536 were determined 195 
by immunoblot analysis. (b) The effect of DK4023 on the TNFα-induced phosphorylation of NF-κB 196 
pathway proteins was determined by immunoblotting. Relative band intensities were measured by 197 
ImageJ. Values are expressed as mean ± SD. *** p < 0.001, NS not significant (p > 0.05) by Sidak’s multiple 198 
comparison test (n = 3). The full-length blot images are presented in Supplementary Figure S2. 199 
2.7. Effect of DK4023 on the TNFα-Induced Expression of Early Growth Response-1 (EGR-1) 200 
EGR-1 is a Cys2His2-type zinc-finger transcription factor induced by mitogenic stimulation and 201 
DNA damage signals [34]. EGR-1 is known to directly bind to the EGR-1-binding element within the 202 
MMP9 gene promoter and transactivate the MMP9 promoter activity upon TNFα stimulation in 203 
HeLa cervical cancer cells [28]. In MDA-MB-231 cells, TNFα increased the level of EGR-1 protein in 204 
a time-dependent manner (Figure 7a). However, DK4023 decreased the TNFα-induced expression of 205 
EGR-1 in a dose-dependent manner (Figure 7b). To evaluate the role of EGR-1 in DK4023-induced 206 
MMP9 suppression, we used the wild-type MMP9 promoter construct and a site-directed mutant 207 
construct obtained by disrupting the EGR-1-binding site (EBS) at MMP9 promoter-reporter. TNFα 208 
stimulated MMP9 promoter activation in the wild-type construct, but its effect was lost following the 209 
disruption of EBS (Figure 7c). DK4023 treatment inhibited the TNFα-induced MMP9 promoter 210 
activation in the wild-type construct. These data suggest that EGR-1 is critical for mediating the 211 
TNFα-induced activation of MMP9 promoter and that EGR-1 downregulation by DK4023 is 212 
associated with the suppression of TNFα-induced MMP9 promoter activation.  213 
Figure 6. Effect of K4023 on the T Fα-induced activation of F-κB path ay. (a) The T Fα-induced
phosphorylation of IKKα/β on Ser-180/181, IκB on Ser-32, and RelA/p65 on Ser-536 ere deter ined
by i unoblot analysis. (b) The effect of DK4023 on the TNFα-induced phosphorylation of NF-κB
pathway proteins was determined by immunoblotting. Relative band intensities were measured by
ImageJ. Values are expressed as mean ± SD. *** p < 0.001, ** p < 0.01, NS not significant (p > 0.05) by
Sidak’s multiple comparison test (n = 3). The full-length blot images are presented in Supplementary
Figure S2.
2.7. Effect of DK4023 on the TNFα-Induced Expression of Early Growth Response-1 (EGR-1)
EGR-1 is a Cys2His2-type zinc-finger transcription factor induced by mitogenic stimulation and
DNA damage signals [34]. EGR-1 is known to directly bind to the EGR-1-binding element within
the MMP9 gene promoter and transactivate the MMP9 promoter activity upon TNFα stimulation in
HeLa cervical cancer cells [28]. In MDA-MB-231 cells, TNFα increased the level of EGR-1 protein in a
time-dependent manner (Figure 7a). However, DK4023 decreased the TNFα-induced expression of
EGR-1 in a dose-dependent manner (Figure 7b). To evaluate the role of EGR-1 in DK4023-induced
MMP9 suppression, we used the wild-type MMP9 promoter construct and a site-directed mutant
construct obtained by disrupting the EGR-1-binding site (EBS) at MMP9 promoter-reporter. TNFα
stimulated MMP9 promoter activation in the wild-type construct, but its effect was lost following
the disruption of EBS (Figure 7c). DK4023 treatment inhibited the TNFα-induced MMP9 promoter
activation in the wild-type construct. These data suggest that EGR-1 is critical for mediating the
TNFα-induced activation of MMP9 promoter and that EGR-1 downregulation by DK4023 is associated
with the suppression of TNFα-induced MMP9 promoter activation.
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Figure 7. Effect of DK4023 on the TNFα-induced expression of EGR-1. (a) The TNFα-induced
accumulation of EGR-1 was determined by immunoblotting. (b) Inhibitory effect of DK4023 on
TNFα-induced EGR-1 accumulation was determined by immunoblotting. Relative band intensities
were measured by ImageJ. The full-length blot images are presented in Supplementary Figure S3.
(c) The effect of the mutation of the EGR-1-binding element in MMP9 promoter-reporter construct,
pMMP9-Luc(−925/+13), on the TNFα-induced activation of MMP9 promoter was determined by
luciferase reporter activity. WT, wild-type; mtEgr1, mutation of the EGR-1-binding sequence. Values
were expressed as mean ± SD. *** p < 0.001, NS not significant (p > 0.05) by Dunnett’s (a,b) or Sidak’s
multiple comparison test (c).
2.8. Effect of DK4023 on the TNFα-Induced Activation of Mitogen-Activated Protein Kinase (MAPK) Pathway
MAPK signaling pathway plays an essential role in mediating the TNFα-induced expression of
EGR-1 in MDA-MB-231 cells [35]. We investigated if DK4023 modulates MAPK pathways by evaluating
its effects on the TNFα-induced phosphorylation of three key MAPKs, extracellular signal-regulated
kinase 1/2 (ERK1/2), c-Jun N-terminal kinase 1/2 (JNK1/2), and p38 kinase, in MDA-MB-231 cells using
phospho-specific antibodies. We found that the phosphorylation of ERK1/2 on Thr-201/Tyr-204, JNK1/2
on Thr-183/Tyr-185, and p38 kinase on Thr-180/Tyr-182 increased within 15 min of TNFα treatment
as compared to that observed under unstimulated condition (Figure 8a). Under these conditions,
pretreatment of MDA-MB-231 cells with DK4023 significantly reduced (p < 0.01, n = 3) the levels of
TNFα-induced ERK1/2, whereas did not affect or slightly increased the phosphorylation of JNK1/2 and
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p38 kinase (Figure 8b). These data suggest that DK4023 reduces TNFα-induced MMP9 expression by
selectively inhibiting the ERK1/2 and EGR-1 signaling axis.
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Figure 8. Effect of DK4023 on the TNFα-induced activation of MAPK pathways. (a) The TNFα-induced
phosphorylation of ERK1/2 on Thr-201/Tyr-204, JNK1/2 on Thr-183/Tyr-185, and p38 on Thr-180/Tyr-182
were determined by im unoblotting. (b) The effect of DK4023 on the TNFα-induced phosphorylation
of MAPKs was determined by immunoblotting. Relative band intensities were measured by ImageJ.
Values were expressed as mean ± SD. ** p < 0.01, NS not significant (p > 0.05) by Dunnett’s multiple
comparison test (n = 3). The full-length blot images are presented in Supplementary Figure S4.
3. Materials and Methods
3.1. Cells and Chemicals
MDA-MB-231 human breast cancer cells were obtained from the American Type Culture Collection
(ATCC, Rockville, MD, USA) and cultured in Dulbecco’s modified Eagle’s medium (Corning Cellgro,
Manassas, VA, USA) supplemented with 10% (v/v) heat-inactivated fetal bovine serum (Corning Cellgro).
TNFα was purchased from Sigma-Aldrich (Saint Louis, MO, USA), and Pierce BCA Protein Assay
Reagent was supplied by Thermo Scientific (Rockford, IL, USA). The Firefly and Renilla Dual-Glo™
Luciferase Assay System was procured from Promega (Madison, WI, USA), and nitrocellulose
membrane, from Bio-Rad Laboratories (Hercules, CA, USA).
3.2. Chemical Synthesis
Commercially available phenylhydrazine (I, 1.10 g, 10 mmol) and 2-(ethoxymethylidene)
propanedinitrile (II, 10 mmol, 1.22 g) were dissolved in 20 mL of an ethanol-water (1:3) solution, and the
resulting ixture was stirred at 25 ◦C for 20 h to obtain an orange color solid. The precipitate was filtered
and washed with cold ethanol. The resulting solid of III, 5-amino-1-phenyl-1H-pyrazole-4-carbonitrile,
was dried and used for the next reaction without any further purification. In brief, 5 mL of toluene
solvent was mixed ith equimolar amounts of 5-amino-1-phenyl-1H-pyrazole-4-carbonitrile (III,
60 mg, 0.3 mmol) and 4-oxo-4H-chromene-3-carbaldehyde (IV, 51 mg, 0.3 mmol), and the mixture was
treated with a catalytic amount of sodium hydroxide (NaOH). The reaction mixture was stirred at 75 ◦C
for 5 h. After reaction completion, the mixture was cooled to room temperature and the solvent was
evaporated under the vacuum. The residues were purified with edium-pressure chromatography to
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obtain an analytically pure compound of V (named DK4023). The structure of DK4023 was verified
using nuclear magnetic resonance (NMR) spectroscopy and high-resolution electrospray ionization
mass spectrometry (HR-ESI-MS) as described previously [36]. Its spectroscopic data are summarized
as follows: IR (cm−1) 3112.55(N-H), 2216.77(-CN), 1657.62(conj. C=O); 1H NMR (500 MHz, DMSO-d6)
δ 9.23 (d, 1H, J = 0.5 Hz), 9.04 (m, 1H), 8.32 (s, 1H), 8.17 (dd, 1H, J = 8.0, 1.5 Hz), 7.90 (m, 1H), 7.76
(dd, 1H, J = 8.5, 0.7 Hz), 7.71 (m, 2H), 7.60 (m, 1H), 7.55 (m, 2H), 7.46 (m, 1H); 13C NMR (125 MHz,
DMSO-d6) δ 174.64 161.00, 160.03, 155.65, 152.23, 142.90, 137.64, 135.18, 129.09, 128.13, 126.75, 125.35,
124.05, 123.64, 118.88, 118.77, 113.86, 81.23, 48.56.; HR-ESI-MS (m/z): Calcd. for C20H12N4O2 [M+H]+:
341.1039; found 341.1036. The raw spectra, including IR, 1H-NMR, 13C-NMR, and HR-ESI-Mass
spectrum, are provided as a Supplementary Figure S5.
3.3. Cytotoxicity Assay
MDA-MB-231 cells cultured in 96-well plates (2 × 103 cells/well) were treated with different
concentrations (10–100 µM) of DK4023 for 24 h. Cell viability was measured by the Cell Counting
Kit-8 (Dojindo Molecular Technologies, Gaithersburg, MD) assay using the water-soluble tetrazolium
salt WST-8, as previously described [37]. The absorbance was read at 540 nm using a microplate reader
(Molecular Devices Corp., Menlo Park, CA).
3.4. Cell Migration Assay
Cell motility was examined using an in vitro scratch-wound healing assay, as previously
described [19]. In brief, MDA-MB-231 cells were cultured in six-well plates and allowed to reach
confluency. A scratch wound was made with a pipette tip on the confluent cell layer, which was then
pretreated with either vehicle (DMSO) or 25 µM DK4023. After 30 min, cells were treated with either
vehicle (PBS) or 10 ng/mL TNFα. Gap closure was imaged at 12 h post-scratching using an EVOS FL
Auto Cell Imaging System (Life Technologies, Carlsbad, CA, USA) and the area of the closed gap was
quantified using ImageJ version 1.52a (http://imagej.nih.gov/ij/; Center for Information Technology,
National Institute of Health, Bethesda, MA, USA).
3.5. Actin Rearrangement
MDA-MB-231 cells were pretreated with either vehicle (DMSO) or DK4023 (25 or 50 µM).
After 30 min, cells were treated with either vehicle (PBS) or TNFα (10 ng/mL) for 24 h, and then fixed
in 4% paraformaldehyde and permeabilized in 0.3% Triton X-100. Actin polymerization was examined
using the rhodamine/phalloidin-based F-Actin Visualization Biochem Kit (Cytoskeleton, Inc.; Denver,
CO, USA) [38]. Images were captured using EVOS FL Auto Cell Imaging System.
3.6. In-Gel Gelatinase Activity Assay
Gelatin zymography was carried out using the Novex Zymogram gel system (Novex, San Diego,
CA), as previously described [39]. In brief, MDA-MB-231 cells (3 × 105) were cultured in a serum-free
medium in 24-well plates for 24 h and then pretreated with either vehicle (DMSO) or DK4023 (25 or
50 µM). After 30 min, cells were treated with either vehicle (PBS) or TNFα (10 ng/mL). After 24 h,
the culture medium was collected following the removal of cell debris and mixed with a non-reducing
sample buffer (62.5 mM Tris-HCl [pH 6.8], 4% SDS, 25% glycerol, and 0.01% bromophenol blue).
Equal amounts of each sample were electrophoresed using Novex pre-cast gels (10% acrylamide-0.1%
gelatin). After electrophoresis, gels were equilibrated by incubation first in Novex Zymogram
renaturation buffer for 30 min and then overnight in Zymogram developing buffer at 37 ◦C. Destaining
was performed in methanol/acetic acid/distilled water (25:7:68, by volume) until gelatinolytic white
bands appeared on the blue background. Relative gelatinolytic activities of MMP2 and MMP9 were
determined by quantifying the white band intensities using ImageJ version 1.52a.
Int. J. Mol. Sci. 2020, 21, 5080 12 of 15
3.7. RT-PCR
The experimental procedures for total RNA isolation, cDNA synthesis, and PCR conditions are
described elsewhere [39]. Briefly, cDNA was synthesized using 1 µg of total RNA and subjected
to PCR using the following gene-specific primers: MMP9 (forward) 5′-agattccaaacctttgag-3′ and
(reverse) 5′-ggccttggaagatgaatg-3′; and GAPDH (forward) 5′-acccactcctccacctttg-3′ and (reverse)
5′-ctcttgtgctcttgctggg-3′. PCR conditions were as follows: denaturation, 94 ◦C for 30 s; annealing, 55 ◦C
for 30 s; elongation, 72 ◦C for 1 min. The amplified products were subjected to electrophoresis on a 1%
agarose gel. The relative MMP9 mRNA level was quantitated after normalizing to GAPDH mRNA
level using ImageJ version 1.52a.
3.8. MMP9 Promoter-Reporter Assay
The generation of the MMP9 promoter construct pMMP9-Luc(−925/+13) and the mutated construct
for EGR-1 binding site, pMMP9-Luc(−925/+13)mtEgr1, was described elsewhere [28]. MDA-MB-231
cells cultured on 12-well plates were transfected with 0.1 µg of MMP9 promoter-reporter constructs
along with 25 ng of the pRL-null plasmid encoding Renilla luciferase to monitor transfection efficiency.
At 48 h post-transfection, cells were pretreated with either vehicle (DMSO) or DK4023 (25 or 50 µM).
After 30 min, cells were treated with either vehicle (PBS) or TNFα (10 ng/mL). After 8 h, cells were
collected and the firefly luciferase activity was measured using a Centro LB960 dual luminometer
(Berthold Technologies) as previously described [28].
3.9. 3-D Spheroid Culture and Invasion Assay
The 3-D invasion assay was carried out using the Cultrex 3-D Spheroid Cell Invasion Assay kit
(Trevigen, Inc., Gaithersburg, MD, USA), as previously described [39]. Briefly, after forming spheroids
of MDA-MB-231 cells, spheroids were embedded in matrigel-based extracellular matrix components
and treated with or without 10 ng/mL TNFα in the presence or absence of 25 µM DK4023 for 7 days.
Invasive protrusions into the surrounding extracellular matrix were visualized with an EVOS® FL
Auto Cell Imaging System (Life Technologies).
3.10. Immunoblot Analysis
Immunoblotting was performed as previously described [28]. In brief, MDA-MB-231 cells were
lysed in a buffer comprising 20 mM HEPES (pH 7.2), 1% Triton X-100, 10% glycerol, 150 mM sodium
hydroxide (NaCl), 10 µg/mL leupeptin, and 1 mM phenylmethylsulfonyl fluoride and electrophoresed
on 10% SDS polyacrylamide gel electrophoresis (PAGE) gels. The separated protein bands were
transferred onto nitrocellulose membranes, which were incubated with appropriate primary and
horseradish peroxidase-conjugated secondary antibodies. The blots were then developed using an
Amersham ECL Western Blotting Detection Kit (GE Healthcare Life Science, Chicago, IL, USA).
3.11. Statistical Analysis
Statistical significance was analyzed using GraphPad PRISM software version 8.2.1 (GraphPad
Software Inc., La Jolla, CA, USA). A value of p < 0.05 was considered significant.
4. Conclusions
The present study identified a novel synthetic isoflavone derivative, DK4023, as an anti-invasive
agent against metastatic breast cancer cells. Natural isoflavones, such as genistein and daidzein, are
known to inhibit TNFα-induced migration and invasion of human breast cancer cells by preventing
the inhibition of NF-κB [17]. This study demonstrated that DK4023 inhibited TNFα-induced migration
and lamellipodium formation of highly metastatic MDA-MB-231 cells. Our findings also show
that DK4023 suppressed TNFα-induced expression of MMP9 mRNA through the downregulation
of the ERK1/2-mediated expression of EGR-1, independently of NF-κB. More importantly, DK4023
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substantially attenuated the invasive capability of MDA-MB-231 breast cancer cells. Although additional
in vivo studies are warranted to validate the clinical efficacy of DK4023 in a metastasis animal model,
we propose that DK4023 can serve as a promising agent to target the TNFα-ERK1/2 MAPK-EGR-1-MMP9
signaling pathway for the development of a chemopreventive or chemotherapeutic adjuvant, which
can be used in combination with conventional chemotherapy, radiotherapy, or immunotherapy against
metastatic cancers, particularly breast cancer.
Supplementary Materials: The following are available online at http://www.mdpi.com/1422-0067/21/14/5080/s1.
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EGR-1 Early growth response-1
ERK Extracellular signal-regulated kinase
GAPDH Glyceraldehyde 3-phosphate dehydrogenase
IκB Inhibitor of nuclear factor-κB
IKK IκB kinase
JNK c-Jun N-terminal kinase
MAPK Mitogen-activated protein kinase
MMP Matrix metallopeptidase
NF-κB Nuclear factor kappa B
RelA v-rel Avian reticuloendotheliosis viral oncogene homolog A
RT-PCR Reverse-transcription polymerase chain reaction
TNFα Tumor necrosis factor alpha
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